| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1191/0961203306LU2293RR |
| P698 | PubMed publication ID | 16634372 |
| P50 | author | Munther A. Khamashta | Q73418907 |
| P2093 | author name string | M L Bertolaccini | |
| P2860 | cites work | Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines | Q22255576 |
| Seronegative antiphospholipid syndrome | Q24674194 | ||
| Thrombosis, abortion, cerebral disease, and the lupus anticoagulant | Q24675412 | ||
| Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke | Q28167141 | ||
| A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS) | Q28174751 | ||
| Characteristics of patients with antiphospholipid syndrome with major bleeding after oral anticoagulant treatment | Q28181800 | ||
| Autoantibodies to vascular heparan sulfate proteoglycan in systemic lupus erythematosus react with endothelial cells and inhibit the formation of thrombin-antithrombin III complexes | Q28259170 | ||
| Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus | Q28261335 | ||
| Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles | Q28268679 | ||
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5. | Q33342481 | ||
| Clinical significance of immunoglobulin A versus immunoglobulins G and M anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion | Q33354998 | ||
| Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients | Q33369688 | ||
| Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders | Q33450363 | ||
| Anticardiolipin antibodies: isotype distribution and phospholipid specificity | Q33456927 | ||
| The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays | Q33497875 | ||
| International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
| Primary prevention of thrombosis in subjects with positive antiphospholipid antibodies | Q34021321 | ||
| Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature | Q34977289 | ||
| Migraine, memory loss, and "multiple sclerosis ". Neurological features of the antiphospholipid (Hughes') syndrome | Q35075610 | ||
| Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome | Q35158386 | ||
| Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002. | Q35189292 | ||
| Antiphospholipid antibody tests: spreading the net | Q35554909 | ||
| Ethnic and geographical variation in antiphospholipid (Hughes) syndrome | Q35555112 | ||
| Management of the obstetric antiphospholipid syndrome | Q35743192 | ||
| Stroke and antiphospholipid syndrome: the treatment debate | Q36102500 | ||
| Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) | Q36242479 | ||
| Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy | Q36242873 | ||
| Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis | Q38553245 | ||
| Pregnancy Loss in the Antiphospholipid-Antibody Syndrome — A Possible Thrombogenic Mechanism | Q41099260 | ||
| Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis | Q41537096 | ||
| Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface | Q42084495 | ||
| Antibodies to factor XII and recurrent fetal loss in patients with the anti-phospholipid syndrome | Q43622727 | ||
| Antiphospholipid (Hughes') syndrome in African-Americans: IgA aCL and abeta2 glycoprotein-I is the most frequent isotype | Q43850415 | ||
| A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome | Q44588720 | ||
| Thromboprophylaxis with unmonitored intermediate-dose low molecular weight heparin in pregnancies with a previous arterial or venous thrombotic event | Q44653622 | ||
| Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics. | Q45239170 | ||
| Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII. | Q45870986 | ||
| Binding of anticardiolipin antibodies to protein C via beta2-glycoprotein I (beta2-GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system | Q47901692 | ||
| Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis | Q48394757 | ||
| IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study. | Q50933721 | ||
| Biochemical characterization of ADP-ribose polymer metabolism in SLE. | Q51031046 | ||
| Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. | Q53354829 | ||
| Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders | Q57089710 | ||
| Accuracy of Anticardiolipin Antibodies in Identifying a History of Thrombosis Among Patients With Systemic Lupus Erythematosus | Q57437612 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 172-178 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Laboratory diagnosis and management challenges in the antiphospholipid syndrome | |
| P478 | volume | 15 |
| Q47727907 | Antigenicity analysis of human parvovirus B19-VP1u protein in the induction of anti-phospholipid syndrome |
| Q36947358 | D-dimer level and the risk for thrombosis in systemic lupus erythematosus |
| Q46855041 | Epidural hematoma mimicking transverse myelitis in a patient with primary antiphospholipid syndrome |
| Q37266831 | Hepatic infarction in a pregnant woman with antiphospholipid syndrome and triple antibody positivity: A case report focusing on catastrophic antiphospholipid syndrome |
| Q39987165 | Immunological detection of in vitro formed phosphatidylethanol--an alcohol biomarker--with monoclonal antibodies. |
| Q40003664 | Multiple thromboses in a patient with systemic lupus erythematosus after splenectomy. |
| Q37802034 | Respiratory involvement in systemic lupus erythematosus |
| Q39404443 | Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome |
| Q79995141 | [Antiphospholipid antibodies and antiphospholipid syndrome: diagnosis and management] |
| Q81416458 | [Coagulopathy resulting from lupus anticoagulant antibodies as a paraneoplastic phenomenon in renal cell carcinoma relapse] |
| Q83079608 | [Respiratory involvement in systemic lupus erythematosus] |
Search more.